Voxel.AI is devoted to developing neuroimaging healthcare products.
We honed our expertise understanding the neurologic basis of elite athletic performance. Our current work is an expansion of those early insights into healthcare. Concussion, stroke, dementia and other debilitating conditions all impact quality of life and all suffer from a lack of clinical tools that can predict outcomes to inform care.
At Voxel.AI, we use MRI sequences not available in traditional healthcare to understand the structural, functional and physiological impacts of an injury or disease. Our AI based, disease-specific algorithms characterize your brain, predict your outcome and guide a path for your recovery.
In 2020 Voxel.AI embarked on a successful fundraising campaign to support the technological and commercial development of healthcare products in the stroke and concussion markets.
Our Team
Peter is a 30+ year veteran of GE Healthcare, having held executive roles in both the Canadian and US markets. His business teams consistently expanded revenue, margin and share across diverse business segments. As Vice President and General Manager of GE Health Care Canada, Peter successfully drove programs around the 2010 Vancouver Olympics, and launched innovative projects in Digital Pathology, Public Private Partnerships and Virtual Care Management.
Peter was active externally, serving as the Chair of MEDEC, Canada’s Trade Association for Biotech, Vice Chair of the Centre for Probe Development and Commercialization, membership on the Corporate Advisory Committee of the College of Health Service Executives and as a member of the Ontario Health Innovation Council.
Peter retired from GE Healthcare in June of 2016 to return home and establish his own consulting firm, focused on innovation, commercialization and business development. He joined Voxel.AI in September of 2019.
Peter, his wife and three children live in the Toronto area.
Dr. DJ Cook
Dr. DJ Cook is a neurosurgeon and neuroscientist. He obtained his MD and PhD from the University of Toronto. Dr. Cook also completed a fellowship in cerebrovascular surgery at Stanford University. Dr. Cook is a faculty member at Queen’s University and the University of Minnesota. His research program focuses on how the brain adapts after injury particularly after stroke and His research program focuses on how the brain adapts after injury, particularly after stroke or traumatic brain injury. He serves on the Board of Directors for Revalesio and Archeoptix. At Voxel.AI, Dr. Cook is the Chief Scientific Officer, co-founder, and he is responsible for overseeing all neuroimaging and data analytics.
Dr. Nicole Coverdale
Nicole Coverdale is a cerebrovascular physiology researcher with expertise in MRI and transcranial Doppler ultrasound. Nicole graduated from the University of Western Ontario with a PhD in Kinesiology with a focus on cerebrovascular physiology. During her post-doctoral training at Queen’s University, she has developed techniques to measure cerebrovascular reactivity with MRI. She is the Director of Scientific Operations at Voxel.AI. Her roles include project management, study coordination and leading funding applications.
Dr. Christopher Murray
Chris Murray is an expert in bioinformatics and big data. He graduated from Johns Hopkins with a PhD in Biological Chemistry and did his postdoctoral work at the University of British Columbia in Biophysics. Currently, he works at Cedars Sinai in Los Angeles with multi-omics data in precision medicine. At Voxel.AI, as the Chief Technology Officer, he is responsible for the design and implementation of the data analytics pipeline to define injury or disease and modeling to predict patient outcome.
Ben is a Founding Partner at Blue Deer Capital Partners, an Exempt Market Dealer headquartered in Toronto that provides advisory services to mission driven entrepreneurs. He is also co-founder and Executive Chairman at Voxel AI. Ben is the Venture Capital and Private Equity Advisor, at Cannonball Capital, a Canadian Family Office. He serves as a Director at Orthogonal and Panaxium and is a Board Observer at Butler Hospitality.
He is the founder of The Butterfly Foundation, which brings together the world’s best and brightest to focus on solving the world’s largest problems, such as global catastrophic biologic risks, AI governance, extreme climate change and nuclear proliferation. He is co-founder of the Lace Em' Up Foundation for Kids, a charity that helps financially disadvantaged children play hockey, and leads its community outreach team. Ben is also a co-founder and Director of the Cannonball Sport and Education Foundation, Co-Founder and Co-Chair of the Breakthrough Fund, a Venture Philanthropy initiative through SickKids Hospital. He is also a Director on the UMass Amherst Foundation, a member of the Milken Young Leaders Circle and was recently awarded The Outstanding Young Alumni Award (21') by the University of Massachusetts Amherst.
Drafted to the NHL in 2010, Ben played four years as a scholar-athlete in Division I NCAA hockey, before graduating from the Isenberg School of Management at the University of Massachusetts Amherst. He is also a graduate of the Institute of Corporate Directors where he received his ICD.D designation.